Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

Clinical trial NCT00091832 · COMPLETED

Trial details

NCT number: NCT00091832
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastases Bone Metastases in Subjects With Advanced Breast Cancer

Start date: 2004-09-01
Primary completion: 2005-11-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.